21 Feb 2023 TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business Press Releases DENVER & CHICAGO–(
21 Feb 2023 U.S. FDA Accepts Biologics License Application for Pfizer’s Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review Press Releases
21 Feb 2023 Beckley Psytech receives FDA Investigational New Drug (IND) approval for Phase IIb study of BPL-003, a novel synthetic formulation of 5-MeO-DMT (Mebufotenin) Press Releases
21 Feb 2023 Delphinus Medical Technologies Appoints Veteran Medical Technology Executive Scott A. White to Chief Commercial Officer Role Press Releases NOVI,…
20 Feb 2023 AZ-3102 Receives Regulatory Designations from FDA, EMA and MHRA from Azafaros Press Releases LEIDEN…
16 Feb 2023 AstraZeneca and Merck Announce Final Results of Secondary Overall Survival Endpoint from Phase III PROpel Trial at ASCO GU Cancers Symposium Press Releases WILMINGTON, Del…
16 Feb 2023 Pfizer Reports Positive Results from Phase 3 TALAPRO-2 Study of TALZENNA® and XTANDI® Combination Therapy Press Releases
16 Feb 2023 Merck and AstraZeneca Announce Final Overall Survival Results From Phase 3 PROpel Trial at 2023 ASCO Genitourinary Cancers Symposium Press Releases
